Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
6-DIG Scintigraphy vs Clamp for Insulin Resistance
NCT02102737Phase 2Completed
- Sponsor
- Inserm
- Start
- May 2014
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 6-deoxy-6-iodo-D-glucose in insulin resistance (IR), type 2 diabetes mellitus (T2DM), sponsored by Inserm. Started May 2014; status: completed.
02
Drugs
6-deoxy-6-iodo-D-glucose
03
Conditions
insulin resistance (IR)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02102737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02102737.